Technical Analysis for CYTO - Altamira Therapeutics Ltd.

Grade Last Price % Change Price Change
F 0.50 3.33% 0.02
CYTO closed up 3.33 percent on Friday, November 1, 2024, on 42 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Very Strong Down Down Down

Date Alert Name Type % Chg
MACD Bullish Signal Line Cross Bullish 0.00%
NR7 Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Lower Bollinger Band Walk Weakness 3.33%
Inside Day Range Contraction 3.33%
Wide Bands Range Expansion 3.33%
Gapped Up Strength 3.33%
New 52 Week Closing Low Bearish 4.04%
180 Bearish Setup Bearish Swing Setup 4.04%
Lower Bollinger Band Walk Weakness 4.04%

   Recent Intraday Alerts

Alert Time
Possible NR7 about 21 hours ago
Up 3% about 22 hours ago
Up 2% about 23 hours ago
Up 1% 1 day ago
Fell Below Previous Day's Low 1 day ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Altamira Therapeutics Ltd. Description

Altamira Therapeutics is a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology, rhinology and allergy and CNS disorders. The Company is focused on the development of intranasal betahistine for the treatment of vertigo (AM-125, in Phase 2) and for the prevention of antipsychotic-induced weight gain and somnolence (AM-201, post Phase 1b). Through its affiliate Altamira Medica, the Company is developing a nasal spray for protection against airborne pathogens and allergens (AM-301). In addition, Auris Medical has two Phase 3 programs under development: Sonsuvi® (AM-111) for acute inner ear hearing loss and Keyzilen® (AM-101) for acute inner ear tinnitus. The Company was founded in 2003 and is headquartered in Hamilton, Bermuda with its main operations in Basel, Switzerland. The shares of Auris Medical Holding Ltd. trade on the NASDAQ Capital Market under the symbol 'EARS.'


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Allergy Nervous System Otology

Is CYTO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 17.2
52 Week Low 0.45
Average Volume 62,710
200-Day Moving Average 1.34
50-Day Moving Average 0.70
20-Day Moving Average 0.57
10-Day Moving Average 0.52
Average True Range 0.05
RSI (14) 32.43
ADX 55.41
+DI 8.20
-DI 26.99
Chandelier Exit (Long, 3 ATRs) 0.51
Chandelier Exit (Short, 3 ATRs) 0.60
Upper Bollinger Bands 0.68
Lower Bollinger Band 0.45
Percent B (%b) 0.2
BandWidth 39.53
MACD Line -0.06
MACD Signal Line -0.06
MACD Histogram 0.0003
Fundamentals Value
Market Cap 787.57 Thousand
Num Shares 1.58 Million
EPS -453.06
Price-to-Earnings (P/E) Ratio 0.00
Price-to-Sales 25.01
Price-to-Book 0.35
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.54
Resistance 3 (R3) 0.54 0.52 0.54
Resistance 2 (R2) 0.52 0.51 0.52 0.53
Resistance 1 (R1) 0.51 0.50 0.51 0.51 0.53
Pivot Point 0.49 0.49 0.49 0.49 0.49
Support 1 (S1) 0.48 0.48 0.49 0.49 0.47
Support 2 (S2) 0.46 0.47 0.46 0.47
Support 3 (S3) 0.45 0.46 0.46
Support 4 (S4) 0.46